Assignee
DEL MAR PHARMACEUTICALS BC LTD
CA·4 granted patents·6 pending applications·2 citations·filing 2013–2023
Top patents by PatentIndex Score
10 records- 0179US11717505B2Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomasDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Granted Aug 8, 2023·1 cites·11 claims
- 0276US2022193024A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 0375US2022142966A1Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2022·Application pending·0 cites
- 0472US11234955B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2019·Granted Feb 1, 2022·0 cites·7 claims
- 0571US10201521B2Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastomaDEL MAR PHARMACEUTICALS BC LTD·Filed 2013·Granted Feb 12, 2019·1 cites·6 claims
- 0669US2023338325A1Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomasDEL MAR PHARMACEUTICALS BC LTD·Filed 2023·Application pending·0 cites
- 0762US2021251944A1Methods for treating a cancer resistant to at least one tyrosine kinase inhibitorDEL MAR PHARMACEUTICALS BC LTD·Filed 2021·Application pending·0 cites
- 0851US10591445B2Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or analogs thereofDEL MAR PHARMACEUTICALS BC LTD·Filed 2016·Granted Mar 17, 2020·0 cites·20 claims
- 0943US2020061054A1Use of dianhydrogalactitol or analogs and derivatives in combination with a p53 modulator or a parp inhibitorDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Application pending·0 cites
- 1039US2020062839A1Use of dianhydrogalactitol or analogs and derivatives in combination with vegf inhibitors to treat cancerDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DEL MAR PHARMACEUTICALS BC LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →